{"id":50954,"date":"2022-11-16T17:02:21","date_gmt":"2022-11-16T16:02:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/"},"modified":"2022-11-16T17:02:21","modified_gmt":"2022-11-16T16:02:21","slug":"aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/","title":{"rendered":"Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month"},"content":{"rendered":"
\n

\nPushing the Future of Lung Cancer Diagnostics Forward<\/b>\n<\/p>\n

WESTON, Mass.–(BUSINESS WIRE)–Aquyre Biosciences<\/a> recognizes Lung Cancer Awareness Month by reaching a milestone of over 400 lung biopsy procedures completed using the CelTivity<\/a>\u2122 microscopic system. CelTivity provides an easy-to-read image, like a PET scan for cells, making cancer cells glow. Physicians found that by using CelTivity they had a significantly higher rate of cancer detection (96%), compared to traditional methods (57%). By using CelTivity, physicians can be more confident in their findings and quickly provide diagnosis guidance to patients.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nCelTivity is the only microscopic system on the market to provide physicians with a non-destructive Rapid On-Site Evaluation (ROSE) of a biopsy for both fine needle aspiration (FNA) and tissue. Powered by proprietary technologies, including Dynamic Cell Imaging\u2122 (DCI), CelTivity analyzes the entire biopsy\u2019s intracellular and metabolic activity. This activity is then presented in a heatmap, making results easy to interpret. The two-minute microscopic evaluation does not require any cutting or staining. As a result, the same tissue evaluated for adequacy is sent unchanged to final pathology for final diagnosis and next generation sequencing (NGS).\n<\/p>\n

\n\u201cWe are thrilled to have quickly reached such a milestone and accelerate the accurate diagnosis of patients,\u201d said Aquyre Biosciences\u2019 CEO Bertrand Le Conte De Poly. \u201cThis rapid adoption is testament to the technology and speaks to the future of diagnostics and advanced treatment options. We look forward to being on the forefront of that.\u201d\n<\/p>\n

\nCelTivity\u2019s ease of use and easy to read imaging has led many top institutions to quickly adopt the system in their biopsy program.\n<\/p>\n

\n\u201cBy using CelTivity, we\u2019ve had over 95% concorded with final pathology. There\u2019d be instances where we would be in a lesion and would see cancer using CelTivity, however traditional ROSE would say they didn\u2019t see anything.\u201d Said Dr. Stephen Kovacs, UPMC Hamot Comprehensive Lung Center, \u201cWe\u2019d send the sample to final pathology and they would agree with us, that there was in fact cancer.\u201d\n<\/p>\n

\nTo learn more about Aquyre Biosciences and CelTivity visit www.aquyre.com<\/a>.\n<\/p>\n

\nAbout Aquyre Biosciences
\n
<\/b>Aquyre Biosciences, Inc is the creator of CelTivity\u2122, the industry leader in two-minute lung biopsy adequacy assessment. Powered by two proprietary technologies including Dynamic Cell Imaging\u2122 (DCI), CelTivity can scan a biopsy and measure intracellular and metabolic activity throughout extracted tissue. This activity is presented in a heatmap, making it easy to interpret. The assessment does not require any cutting or staining, meaning the same tissue accessed for adequacy can go to final pathology to review for cancer, granuloma, lymphocytes, and more. Aquyre Biosciences is headquartered out of Weston, Mass. For more information, please visit www.aquyre.com<\/a>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nEmily Ritacco
\n
Director of Marketing, Aquyre Biosciences
\n
eritacco@aquyre.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Pushing the Future of Lung Cancer Diagnostics Forward WESTON, Mass.–(BUSINESS WIRE)–Aquyre Biosciences recognizes Lung Cancer Awareness Month by reaching a milestone of over 400 lung biopsy procedures completed using the CelTivity\u2122 microscopic system. CelTivity provides an easy-to-read image, like a PET scan for cells, making cancer cells glow. Physicians found that by using CelTivity they … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50954","6":"format-standard","7":"category-industry"},"yoast_head":"\nAquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Pushing the Future of Lung Cancer Diagnostics Forward WESTON, Mass.–(BUSINESS WIRE)–Aquyre Biosciences recognizes Lung Cancer Awareness Month by reaching a milestone of over 400 lung biopsy procedures completed using the CelTivity\u2122 microscopic system. CelTivity provides an easy-to-read image, like a PET scan for cells, making cancer cells glow. Physicians found that by using CelTivity they ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-16T16:02:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221115006522\/en\/1639010\/21\/Press_Release_PET_and_Histo-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month\",\"datePublished\":\"2022-11-16T16:02:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/\"},\"wordCount\":463,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115006522\\\/en\\\/1639010\\\/21\\\/Press_Release_PET_and_Histo-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/\",\"name\":\"Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115006522\\\/en\\\/1639010\\\/21\\\/Press_Release_PET_and_Histo-01.jpg\",\"datePublished\":\"2022-11-16T16:02:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115006522\\\/en\\\/1639010\\\/21\\\/Press_Release_PET_and_Histo-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221115006522\\\/en\\\/1639010\\\/21\\\/Press_Release_PET_and_Histo-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/","og_locale":"en_US","og_type":"article","og_title":"Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month - Pharma Trend","og_description":"Pushing the Future of Lung Cancer Diagnostics Forward WESTON, Mass.–(BUSINESS WIRE)–Aquyre Biosciences recognizes Lung Cancer Awareness Month by reaching a milestone of over 400 lung biopsy procedures completed using the CelTivity\u2122 microscopic system. CelTivity provides an easy-to-read image, like a PET scan for cells, making cancer cells glow. Physicians found that by using CelTivity they ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-16T16:02:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221115006522\/en\/1639010\/21\/Press_Release_PET_and_Histo-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month","datePublished":"2022-11-16T16:02:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/"},"wordCount":463,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221115006522\/en\/1639010\/21\/Press_Release_PET_and_Histo-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/","url":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/","name":"Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221115006522\/en\/1639010\/21\/Press_Release_PET_and_Histo-01.jpg","datePublished":"2022-11-16T16:02:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221115006522\/en\/1639010\/21\/Press_Release_PET_and_Histo-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221115006522\/en\/1639010\/21\/Press_Release_PET_and_Histo-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aquyre-biosciences-reaches-major-procedure-milestone-during-lung-awareness-month\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Aquyre Biosciences Reaches Major Procedure Milestone During Lung Awareness Month"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50954"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50954\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50954"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50954"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}